New patent for Myovant Sciences drug MYFEMBREE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MYFEMBREE
Annual Drug Patent Expirations for MYFEMBREE

Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are four patents protecting this drug.

This drug has seventy patent family members in twenty-nine countries.

The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix. Additional details are available on the estradiol; norethindrone acetate; relugolix profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top